10206-89-0 Usage
Uses
Used in Biochemical Research:
EXP561 is used as a research reagent for studying the role of glutathione reductase in cellular processes due to its inhibitory effect on the enzyme.
Used in Organic Synthesis:
In the field of organic synthesis, EXP561 is utilized as a chemical compound for the synthesis of other organic compounds.
Used in Pharmaceutical Development:
EXP561 is used as a potential therapeutic agent for conditions associated with oxidative stress, given its ability to inhibit glutathione reductase.
Used in Antioxidant and Anti-inflammatory Research:
EXP561 is employed as a tool in understanding the molecular mechanisms of redox regulation and in drug discovery efforts targeting oxidative stress-related diseases, due to its potential antioxidant and anti-inflammatory properties.
Used in Drug Discovery for Oxidative Stress-Related Diseases:
In the pharmaceutical industry, EXP561 is used as a lead compound in the development of new drugs aimed at treating diseases related to oxidative stress, leveraging its inhibitory activity on glutathione reductase.
Check Digit Verification of cas no
The CAS Registry Mumber 10206-89-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,0 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10206-89:
(7*1)+(6*0)+(5*2)+(4*0)+(3*6)+(2*8)+(1*9)=60
60 % 10 = 0
So 10206-89-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H19N/c15-14-9-6-13(7-10-14,8-11-14)12-4-2-1-3-5-12/h1-5H,6-11,15H2
10206-89-0Relevant academic research and scientific papers
TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE
-
Page/Page column 71, (2017/10/18)
The present invention provides compounds of Formula (I). wherein A and Z are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
